dx 9065a has been researched along with nitrites in 1 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (nitrites) | Trials (nitrites) | Recent Studies (post-2010) (nitrites) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 19,921 | 501 | 6,075 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enkhbaatar, P; Isobe, H; Okabe, H; Okajima, K; Uchiba, M | 1 |
1 other study(ies) available for dx 9065a and nitrites
| Article | Year |
|---|---|
Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide.
Topics: Animals; Dansyl Compounds; Enzyme Induction; Enzyme Inhibitors; Factor VIIa; Factor Xa Inhibitors; Gene Expression Regulation; Humans; Hypotension; Lipopolysaccharides; Lipoproteins; Lung; Male; Naphthalenes; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Propionates; Rats; Rats, Wistar; Recombinant Fusion Proteins; Respiratory Distress Syndrome; RNA, Messenger; Shock, Septic; Specific Pathogen-Free Organisms; Tumor Necrosis Factor-alpha | 2001 |